Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A pair of rat anti-mouse CD4 monoclonal antibodies (mAb) have been selected which bind to different epitopes of the molecule. Both the mAb are rat IgG2b and show clear synergistic activity in complement lysis in vitro. When injected together in vivo, they exhibit an improved immunosuppressive effect, compared to each antibody alone, on allogeneic graft rejection, humoral responses and on tolerance induction. Limiting dilution analysis indicates that the in vivo depletion of interleukin 2-producing cells is improved using both mAb by 2-3-fold over that obtained with the individual antibodies. As little as 60 ng per mouse of the CD4 antibody pair was sufficient to allow the induction of tolerance to human gamma-globulin, even without elimination of the CD4+ cells. The results suggest that appropriate antibody pairs may be good candidates for effective immunosuppressive serotherapy in man.

Original publication

DOI

10.1002/eji.1830170813

Type

Journal article

Journal

Eur J Immunol

Publication Date

08/1987

Volume

17

Pages

1159 - 1165

Keywords

Animals, Antibodies, Monoclonal, Antibody Formation, Antibody Specificity, Antigens, Differentiation, T-Lymphocyte, Antigens, Surface, Binding, Competitive, Complement Activation, Epitopes, Graft Rejection, Immune Tolerance, Immunosuppression, Interleukin-2, Mice